Affimed N.V.: Q3 Earnings Snapshot
By AP News
Published - Nov 14, 2024, 06:38 AM ET
Last Updated - Dec 16, 2024, 05:25 PM EST
MANNHEIM, Germany (AP) — MANNHEIM, Germany (AP) — Affimed N.V. (AFMD) on Thursday reported a loss of $16.6 million in its third quarter.
On a per-share basis, the Mannheim, Germany-based company said it had a loss of $1.03.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.14 per share.
The drug developer posted revenue of $170,400 in the period. Its adjusted revenue was $170,000.
